NanoFlex, based at the Sci-Tech Daresbury science campus, has received a £250,000 investment from the Northern Powerhouse Investment Fund (NPIF). The funding is aimed at propelling their innovative diagnostic sensor technology into new markets, particularly within healthcare and well-being.
This investment is expected to foster the development of a product pipeline, enhancing the company’s ability to bring cutting-edge sensors to market. The initiative is supported by NPIF – Maven Equity Finance and overseen by MSIF in the Liverpool City Region.
Investment Details
NanoFlex, a sensor design company headquartered at the Sci-Tech Daresbury science campus, successfully secured £250,000 from the Northern Powerhouse Investment Fund (NPIF). This investment is facilitated by NPIF – Maven Equity Finance, specifically for the Liverpool City Region. The funding is poised to create new business avenues for NanoFlex, with a targeted approach towards developing a pipeline of innovative products.
Technology and Applications
NanoFlex specialises in patented diagnostic sensor technology aimed predominantly at the healthcare & fitness and well-being markets. These sensors have the capability to be integrated into various customer products, with an early focus on collaboration with Alder Hey hospital. There is potential for these sensors to play a significant role in monitoring tools for wound care and sepsis. The technology is anticipated to revolutionise healthcare monitoring.
Market Potential and Future Outlook
The CEO of NanoFlex, Neville Freeman, expressed excitement about the investment, stating, “We are very excited to receive this funding as it will enable us to accelerate the rollout of our technology and we expect to see more devices featuring NanoFlex innovation in the near future.” The company plans for the first volume-manufactured products to reach the market by Q1/Q2 2018.
Supporting Statements from Key Figures
Andy Round, MSIF investment director who managed the investment on behalf of Maven, stated, “We are delighted to be able to support NanoFlex and allow them to continue working on further developing their diagnostic sensor technology. The technology they are working on could have a massive impact on our health sector, so I’m excited to see what Neville and the team design in the near future.”
European Funding and Support
This EU support underscores the importance of collaborative efforts in advancing diagnostic technologies. Through such initiatives, NanoFlex can leverage both financial and strategic resources to enhance their R&D capabilities and market reach.
Strategic Collaboration with Alder Hey Hospital
By working closely with medical professionals and healthcare institutions, NanoFlex aims to ensure that their products meet the rigorous standards and needs of the healthcare industry. This will be crucial in establishing credibility and securing future contracts.
Impact on the Healthcare Sector
The funding from NPIF will enable NanoFlex to accelerate their development timelines, bringing these vital healthcare tools to market more swiftly. This is a critical step in addressing some of the current gaps in healthcare technology.
The £250,000 investment from NPIF marks a significant milestone for NanoFlex, facilitating the acceleration of their diagnostic sensor technology. With backing from European funds and strategic collaborations, particularly with Alder Hey hospital, the company is well-positioned to make impactful strides in the healthcare sector.
NanoFlex’s commitment to innovation and excellence, supported by substantial financial and strategic resources, promises to deliver advanced diagnostic solutions that could transform healthcare monitoring and patient care on a broader scale.
